These tumor-infiltrating TAM are skewed toward CD163+ M2 phenotype under the action of the transcription factor, GATA3, and cytokines, including IL-4, IL-6, and IL-13, and promoted an immunosuppressive TME in EAC (33). This evidence concerns the gene IL4 and neoplasm.